WO2009073782A3 - Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue - Google Patents
Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue Download PDFInfo
- Publication number
- WO2009073782A3 WO2009073782A3 PCT/US2008/085530 US2008085530W WO2009073782A3 WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3 US 2008085530 W US2008085530 W US 2008085530W WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proliferative
- pelvic
- treatment
- methods
- proliferative agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Abstract
A pelvic treatment device for localized delivery of one or more anti-proliferative agents to prevent further growth and development of female or male pelvic proliferative cells. With the benefit of localized delivery of the anti-proliferative agents, the anti-proliferative agents can be introduced to pelvic proliferative cells at dosage levels less than would be expected for conventional system delivery mechanisms so as to reduce or eliminated common side effects or toxic conditions. Generally, the one or more anti-proliferative drugs can be introduced in conjunction with or integral to a physical element that retains the anti-proliferative agents for localized release.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99221107P | 2007-12-04 | 2007-12-04 | |
US60/992,211 | 2007-12-04 | ||
US7563308P | 2008-06-25 | 2008-06-25 | |
US61/075,633 | 2008-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009073782A2 WO2009073782A2 (en) | 2009-06-11 |
WO2009073782A3 true WO2009073782A3 (en) | 2009-12-30 |
Family
ID=40718494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/085530 WO2009073782A2 (en) | 2007-12-04 | 2008-12-04 | Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009073782A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8597262B2 (en) * | 2009-07-09 | 2013-12-03 | Ams Research Corporation | Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6086909A (en) * | 1997-06-11 | 2000-07-11 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US6726923B2 (en) * | 2001-01-16 | 2004-04-27 | Vascular Therapies, Llc | Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
US20070026042A1 (en) * | 2005-07-29 | 2007-02-01 | Narayanan Pallasssana V | System for treating aneurysmal disease |
US20070049973A1 (en) * | 2005-08-29 | 2007-03-01 | Vascular Control Systems, Inc. | Method and device for treating adenomyosis and endometriosis |
US20070244071A1 (en) * | 2006-03-07 | 2007-10-18 | Mount Sinai Hospital | Treatment of proliferative diseases |
-
2008
- 2008-12-04 WO PCT/US2008/085530 patent/WO2009073782A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6086909A (en) * | 1997-06-11 | 2000-07-11 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US6726923B2 (en) * | 2001-01-16 | 2004-04-27 | Vascular Therapies, Llc | Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
US20070026042A1 (en) * | 2005-07-29 | 2007-02-01 | Narayanan Pallasssana V | System for treating aneurysmal disease |
US20070049973A1 (en) * | 2005-08-29 | 2007-03-01 | Vascular Control Systems, Inc. | Method and device for treating adenomyosis and endometriosis |
US20070244071A1 (en) * | 2006-03-07 | 2007-10-18 | Mount Sinai Hospital | Treatment of proliferative diseases |
Also Published As
Publication number | Publication date |
---|---|
WO2009073782A2 (en) | 2009-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012034685A3 (en) | Implant delivery device intended to be attached to or interconnected with a catheter, implant delivery catheter and method | |
WO2006053308A3 (en) | Improved energy delivery devices and methods | |
CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
WO2006053309A3 (en) | Improved energy delivery devices and methods | |
IL202614A0 (en) | Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs | |
TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
EP2552356A4 (en) | Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen | |
AP2011005780A0 (en) | Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient. | |
WO2008151299A3 (en) | Implantable medical devices for local and regional treatment | |
WO2011041221A3 (en) | Water treatment cartridge | |
EP2019646A4 (en) | Method, device, and system for delivery of therapeutic agents to the eye | |
WO2011041633A3 (en) | Bottle for water treatment device | |
WO2009031606A1 (en) | Therapeutic and prophylactic agents for arthritis | |
NZ592049A (en) | Compositions and methods for the treatment of bowel diseases with granulated mesalamine | |
MX2016011333A (en) | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. | |
WO2009073307A3 (en) | Implantable medical devices for local and regional treatment | |
WO2014036556A3 (en) | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine | |
WO2012011109A3 (en) | Method for treating urinary incontinence | |
EP2789338A3 (en) | Condensed pyridine derivate and use thereof | |
BR112012013011A2 (en) | odt; odt composition; method for preparing a multiparticulate odt tablet, method for treating or preventing postoperative nausea and vomiting or post-discharge nausea and vomiting for up to 24 hours after dosing, method for treating pu preventing nausea for up to 24 hours after dosing and Method for treating or preventing nausea and vomiting associated with radiotherapy in patients receiving either full body irradiation, single high dose to the abdomen, or daily fractions to the abdomen for up to 24 hours after dosing. | |
MX2012007234A (en) | Calcipotriol monohydrate nanocrystals. | |
WO2009073782A3 (en) | Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue | |
MY164112A (en) | A combination composition comprising ibuprofen and paracetamol | |
WO2009111681A3 (en) | Gallium compounds and methods of use to treat inflammatory bowel disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08856678 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08856678 Country of ref document: EP Kind code of ref document: A2 |